Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:58 pm Purchase | 13G | TALPHERA, INC. TLPH | ARMISTICE CAPITAL LLC | 890,346 4.99% | 26,018 (+3.01%) | View |
| 2024-02-13 8:00 pm Sale | 13G | TALPHERA, INC. TLPH | Lind Global Fund II LP | 735,296 4.2% | -367,648 (-33.33%) | View |
| 2024-01-22 6:46 pm Purchase | 13D | TALPHERA, INC. TLPH | Nantahala Capital Management LLC | 1,992,519 11.8% | 1,992,519 (New Position) | View |
| 2023-07-31 7:50 pm Purchase | 13G | TALPHERA, INC. TLPH | Lind Global Fund II LP | 1,102,944 6.5% | 1,102,944 (New Position) | View |
| 2023-02-14 11:50 am Purchase | 13G | TALPHERA, INC. TLPH | ARMISTICE CAPITAL LLC | 864,328 9.99% | 864,328 (New Position) | View |
| 2022-02-14 6:43 pm Purchase | 13G | ACELRX PHARMACEUTICALS INC ACRX | ARMISTICE CAPITAL LLC | 12,314,479 9.99% | 12,314,479 (New Position) | View |
| 2022-01-27 2:51 pm Sale | 13G | ACELRX PHARMACEUTICALS INC ACRX | BML Investment Partners L.P. | 0 0% | -5,956,000 (Position Closed) | View |
| 2021-07-12 08:29 am Sale | 13G | ACELRX PHARMACEUTICALS INC ACRX | BlackRock Inc. BLK | 2,266,040 1.9% | -3,374,906 (-59.83%) | View |
| 2021-02-10 2:58 pm Purchase | 13G | ACELRX PHARMACEUTICALS INC ACRX | BML Investment Partners L.P. | 5,956,000 6% | 1,198,197 (+25.18%) | View |
| 2021-01-28 5:55 pm Purchase | 13G | ACELRX PHARMACEUTICALS INC ACRX | BlackRock Inc. BLK | 5,640,946 5.7% | 28,929 (+0.52%) | View |
| 2020-10-27 4:04 pm Unchanged | 13G | ACELRX PHARMACEUTICALS INC ACRX | BML Investment Partners L.P. | 4,757,803 5.3% | 0 (Unchanged) | View |
| 2020-10-27 3:50 pm Purchase | 13G | ACELRX PHARMACEUTICALS INC ACRX | BML Investment Partners L.P. | 4,757,803 5.3% | 4,757,803 (New Position) | View |
| 2020-02-07 08:45 am Purchase | 13G | ACELRX PHARMACEUTICALS INC ACRX | BlackRock Inc. BLK | 5,612,017 7.1% | 5,612,017 (New Position) | View |